" Aeterna Zentaris (TSX:AEZS) updates results from pre-clinical studies of its AIM Biologicals platform

Aeterna Zentaris (AEZS) has updated results from pre-clinical studies of its AIM Biologicals platform to treat Parkinson’s disease.

" Aeterna Zentaris (TSX:AEZS) engages Dr. Michael Levy to support the development of Autoimmune and Inflammatory CNS Disorders Programs

Dr. Levy will provide support and advice to Aeterna Zentaris in the fields of inflammatory CNS disorders, autoimmune diseases and NMOSD.